Update on the oncologic and obstetric outcomes of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial cancer

Documenti analoghi

• Spatial distribution of tumor‐resident macrophages as predictive biomarkers in endometrial cancer
  di: Tetsuya Matsukawa, et al.
  Pubblicazione: (2024)
• Diagnostic Use of the Combination of CA72 ‐4 and Tumor Volume in Mucinous Ovarian Tumors
  di: Hajime Araki, et al.
  Pubblicazione: (2025)
• Utility of manual vacuum aspiration followed by curettage in the treating hydatidiform mole: A retrospective analysis
  di: Ui Aoki, et al.
  Pubblicazione: (2025)
• Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2021 and annual treatment report for 2016
  di: Hiroaki Kajiyama, et al.
  Pubblicazione: (2024)
• Time interval from biopsy of endometrial atypical hyperplasia to surgery and risk for concurrent endometrial carcinoma – A retrospective study
  di: Gabriel Levin, et al.
  Pubblicazione: (2024)